Pancreatic Cancer Research

ResearcherFudan UniversityNo recent work listed

Jiali Du

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0795-8409; OpenAlex author ID A5016460782. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper · 2022: 5 papers

Papers 7

  1. High Glucose Promotes Pancreatic Ductal Adenocarcinoma Gemcitabine Resistance and Invasion through Modulating ROS/MMP-3 Signaling Pathway. Co-author DOI 10.1155/2022/3243647↗
  2. The expression and survival significance of sodium glucose transporters in pancreatic cancer. Co-author DOI 10.1186/s12885-021-09060-4↗
  3. The Intricate Crosstalk Between Insulin and Pancreatic Ductal Adenocarcinoma: A Review From Clinical to Molecular. Co-author DOI 10.3389/fcell.2022.844028↗
  4. Gemcitabine-Loaded Albumin Nanoparticle Exerts An Antitumor Effect on Gemcitabine-Resistant Pancreatic Cancer Cells Induced by MDR1 and MRP1 Overexpression in … First author DOI 10.3389/fsurg.2022.890412↗
  5. CDCA8/SNAI2 Complex Activates CD44 to Promote Proliferation and Invasion of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers14215434↗
  6. The Expression and Survival Significance of Glucose Transporter-1 in Pancreatic Cancer: Meta-Analysis, Bioinformatics Analysis and Retrospective Study. Co-author DOI 10.1080/07357907.2021.1950755↗
  7. Mechanisms of drug resistance of pancreatic ductal adenocarcinoma at different levels. Co-author DOI 10.1042/bsr20200401↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jichun Gu · 7 shared papers, 2020–2022 · strength 1.10
  2. Junyuan Deng · 6 shared papers, 2021–2022 · strength 0.91
  3. Lei Kong · 6 shared papers, 2021–2022 · strength 0.91
  4. Ji Li · 5 shared papers, 2020–2022 · strength 0.79
  5. Deliang Fu · 5 shared papers, 2021–2022 · strength 0.76
  6. Baian Tao · 3 shared papers, 2022 · strength 0.46
  7. Chen Jin · 3 shared papers, 2021–2022 · strength 0.45
  8. Ji Li · 1 shared paper, 2022 · strength 0.16
  9. Ji Li · 1 shared paper, 2022 · strength 0.15
  10. Deliang Fu · 1 shared paper, 2022 · strength 0.15
  11. Hengchao Li · 1 shared paper, 2022 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.